As Healio previously reported, a study by Bian and colleagues published earlier this year showed older adults with cancer and type 2 diabetes who used GLP-1 receptor agonists exhibited significantly lower risk for all-cause mortality than those treated with dipeptidyl peptidase-4 inhibitors
The combination group had a significantly lower 10-year atherosclerosis and cardiovascular disease risk (a multicomponent measure of risk of a cardiac event within a 10-year window) at the end of the study compared with the statin-only group
140 In clear-cell ovarian cancer (OCCC), the glutaminase inhibitor CB-839 inhibited ARID1A (AT-rich interactive domain-containing protein 1A) -mutated PDX tumor growth
A: Most research and clinical guidelines suggest a daily intake of 250 mg to 600 mg for adults
Sweet and juicy, these are an easy swap for a sugary snack or dessert
Russian clinical trials over 30 years have reported benefits in elderly patients with cardiovascular and metabolic disease, though the trial methodology and reporting standards dont always match what Western research expects
